XML 177 R120.htm IDEA: XBRL DOCUMENT v3.25.0.1
Other non-current assets - Summary of Other Non-current Assets (Details) - EUR (€)
€ in Millions
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disclosure Of Other Non Current Assets [Line Items]      
Other financial assets at fair value through profit or loss € 1,027 € 808 € 823
Pre-funded pension obligations 156 271 269
Long-term prepaid expenses 152 114 286
Non current loans and receivables [1] 502 591 452
Derivative financial instruments 0 0 0
Other non-current assets 3,753 3,218 3,095
Non-current finance lease receivables 116 132  
Other current assets 3,826 3,455 3,532
Non-current finance lease receivables, gross 181 195  
BioAtrium      
Disclosure Of Other Non Current Assets [Line Items]      
Other current assets     156
Trading equity securities      
Disclosure Of Other Non Current Assets [Line Items]      
Fair value through other comprehensive income 1,559 1,088 936
Debt securities      
Disclosure Of Other Non Current Assets [Line Items]      
Fair value through other comprehensive income € 357 € 346 € 329
[1] (a)As of December 31, 2024, this line includes:
–Loan of €149 million to the BioAtrium joint venture which matures on December 1, 2031, of which €156 million was recognized in "Other current
assets" as of December 31, 2022;
–a receivable under a sub-lease amounting to €116 million (€181 million before discounting), versus €132 million (or €195 million before discounting) as
of December 31, 2023